INTERNATIONAL PATENT: BETTA PHARMACEUTICALS CO., LTD, 贝达药业股份有限公司 FILES APPLICATION FOR "COMPOUND TARGETING UBIQUITIN KRAS PROTEIN DEGRADATION AGENT AND USE THEREOF"

GENEVA, June 1 -- BETTA PHARMACEUTICALS CO., LTD (355 Xingzhong RD., Linping,Hangzhou, Zhejiang 311100), 贝达药业股份有限公司 (中国浙江省杭州市临平经济技术开发区兴中路355号) filed a patent application (PCT/CN2024/097697) for "COMPOUND TARGETING UBIQUITIN KRAS PROTEIN DEGRADATION AGENT, AND USE THEREOF" on Jun 06, 2024. With publication no. WO/2025/107579, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by th...